• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在血浆浓度升高相关临床情况下,凝血因子VIII血管性血友病因子的改变。

Alterations of factor VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration.

作者信息

Lombardi R, Mannucci P M, Seghatchian M J, Garcia V V, Coppola R

出版信息

Br J Haematol. 1981 Sep;49(1):61-8. doi: 10.1111/j.1365-2141.1981.tb07197.x.

DOI:10.1111/j.1365-2141.1981.tb07197.x
PMID:6791681
Abstract

Factor VIII-related antigen (VIIIR:Ag) was consistently higher than factor-VIII procoagulant activity (VIII:C) in 57 patients with clinical conditions characterized by acute-phase reactions. Two different methods for measuring VIII:C (one- and two-stage assays) and VIIIR:Ag (electroimmunodiffusion and immunoradiometric assay) gave concordant results in the majority of cases. In 43% of plasma samples, crossed immunoelectrophoresis in agarose gel was characterized by the appearance of an additional, fast-moving precipitin peak which was immunologically identical with the major, slower-moving VIIIR:Ag peak. The fast-moving peak was detected in all the patients with clinical conditions typically associated with increased plasma proteolysis (DIC, acute pancreatitis, during thrombolytic therapy). It was present in a smaller proportion of cases with liver and renal failure and malignancies and in the post-operative period. The additional VIIIR:Ag peak is thought to be the result of in vivo factor VIII/von Willebrand factor fragmentation by proteolytic enzymes.

摘要

在57例以急性期反应为特征的临床疾病患者中,VIII相关抗原(VIIIR:Ag)始终高于VIII凝血促酶活性(VIII:C)。两种不同的测量VIII:C的方法(一期和二期检测法)以及测量VIIIR:Ag的方法(电免疫扩散法和免疫放射分析)在大多数情况下结果一致。在43%的血浆样本中,琼脂糖凝胶交叉免疫电泳的特征是出现一个额外的、快速移动的沉淀素峰,其在免疫学上与主要的、移动较慢的VIIIR:Ag峰相同。在所有典型的与血浆蛋白水解增加相关的临床疾病患者(弥散性血管内凝血、急性胰腺炎、溶栓治疗期间)中均检测到快速移动峰。在肝功能衰竭、肾功能衰竭、恶性肿瘤患者以及术后患者中,出现该峰的比例较小。额外的VIIIR:Ag峰被认为是体内蛋白水解酶使VIII因子/血管性血友病因子片段化的结果。

相似文献

1
Alterations of factor VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration.在血浆浓度升高相关临床情况下,凝血因子VIII血管性血友病因子的改变。
Br J Haematol. 1981 Sep;49(1):61-8. doi: 10.1111/j.1365-2141.1981.tb07197.x.
2
Factor VIII procoagulant activity, factor VIII related antigen and von Willebrand factor in newborn cord blood.新生儿脐带血中的凝血因子VIII促凝活性、凝血因子VIII相关抗原及血管性血友病因子
Br J Haematol. 1979 Aug;42(4):637-46. doi: 10.1111/j.1365-2141.1979.tb01176.x.
3
Heterogeneity of sugar composition of factor VIII/von Willebrand factor in von Willebrand's disease: analysis by crossed affinoimmunoelectrophoresis using lectin (ricinus communis agglutinin-120).血管性血友病中因子VIII/血管性血友病因子糖组成的异质性:使用凝集素(蓖麻凝集素-120)通过交叉亲和免疫电泳进行分析。
Thromb Haemost. 1983 Apr 28;49(2):87-90.
4
Factor VIII (procoagulant activity VIII:C, and antigen VIII:CAg, related antigen VIIIR:Ag and ristocetin cofactor VIIIR:Cof) in intensive care patients with clinically suspected disseminated intravascular coagulation (DIC).临床疑似弥散性血管内凝血(DIC)的重症监护患者的凝血因子VIII(促凝血活性VIII:C、抗原VIII:CAg、相关抗原VIIIR:Ag和瑞斯托菌素辅因子VIIIR:Cof)
Am J Clin Pathol. 1984 Nov;82(5):565-72. doi: 10.1093/ajcp/82.5.565.
5
[Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].[临床预期发生血管内凝血患者的凝血因子VIII(凝血活性VIII:C、抗原浓度VIIIR:Ag和血管性血友病因子)]
Schweiz Med Wochenschr. 1981 Oct 10;111(41):1542-3.
6
Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease.血管性血友病中凝血因子VIII/血管性血友病因子分子大小的异质性
Thromb Haemost. 1981 Jun 30;45(3):272-5.
7
Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.经典(I型)和变异型(IIA型)血管性血友病亚型中VIII因子/血管性血友病因子的多聚体结构、抗原特性及血浆-血小板含量的异质性异常
J Lab Clin Med. 1983 Mar;101(3):411-25.
8
A critical evaluation of the available methods for the determination of factor VIII von Willebrand.对测定血管性血友病因子 VIII 现有方法的批判性评估。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1986;113(5):670-84.
9
Modification of factor VIII complex properties in patients with liver disease.肝病患者中因子VIII复合物特性的改变。
J Clin Pathol. 1977 Mar;30(3):221-7. doi: 10.1136/jcp.30.3.221.
10
Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.糖尿病大鼠体外血小板功能及血浆血管性血友病因子活性(VIIIR:WF)和因子VIII相关抗原(VIIIR:Ag)变化的时间进程。
J Lab Clin Med. 1983 Nov;102(5):795-804.

引用本文的文献

1
Soluble mannose receptor CD206 and von Willebrand factor are early biomarkers to identify patients at risk for severe or necrotizing acute pancreatitis.可溶性甘露糖受体CD206和血管性血友病因子是用于识别重症或坏死性急性胰腺炎高危患者的早期生物标志物。
J Intensive Care. 2022 Jun 11;10(1):28. doi: 10.1186/s40560-022-00619-2.
2
Closing the gap - detection of clinically relevant von Willebrand disease in emergency settings through an improved algorithm based on rotational Thromboelastometry.缩小差距 - 通过基于旋转血栓弹性描记术的改良算法在急诊环境中检测临床相关的血管性血友病。
BMC Anesthesiol. 2019 Jan 10;19(1):10. doi: 10.1186/s12871-018-0672-8.
3
Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site.
白细胞蛋白酶在ADAMTS13裂解位点或其附近裂解血管性血友病因子。
Blood. 2009 Aug 20;114(8):1666-74. doi: 10.1182/blood-2009-01-195461. Epub 2009 Jun 18.
4
Serum concentrations of von Willebrand factor and soluble thrombomodulin indicate alteration of endothelial function in inflammatory bowel diseases.血管性血友病因子和可溶性血栓调节蛋白的血清浓度表明炎症性肠病中内皮功能的改变。
Dig Dis Sci. 1995 Apr;40(4):793-9. doi: 10.1007/BF02064981.
5
Haemostatic alterations in malaria correlate to parasitaemia.疟疾中的止血改变与寄生虫血症相关。
Blut. 1985 Nov;51(5):329-35. doi: 10.1007/BF00320043.
6
Studies on platelet surface carbohydrates in normal and uraemic platelets using 125I-labelled lectins.使用¹²⁵I标记凝集素对正常及尿毒症血小板表面碳水化合物的研究。
Blut. 1985 May;50(5):287-92. doi: 10.1007/BF00319754.
7
Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo.纤溶酶对血管性血友病因子多聚体的影响。体外降解及体内释放刺激。
J Clin Invest. 1985 Jul;76(1):261-70. doi: 10.1172/JCI111956.
8
Increased factor VIII/vWf levels in patients with reduced platelet number.血小板数量减少患者的凝血因子VIII/vWf水平升高。
Blut. 1987 May;54(5):281-8. doi: 10.1007/BF00320876.
9
The haemostatic effects of hydroxyethyl starch (HES) used as a volume expander.用作容量扩张剂的羟乙基淀粉(HES)的止血作用。
Intensive Care Med. 1985;11(6):300-3. doi: 10.1007/BF00273540.